Swiss National Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $38.6M | Sell |
|
|||||
|
2025
Q2 | $40.2M | Buy |
|
|||||
|
2025
Q1 | $33.2M | Sell |
|
|||||
|
2024
Q4 | $27.5M | Sell |
|
|||||
|
2024
Q3 | $32.3M | Buy |
|
|||||
|
2024
Q2 | $29.6M | Sell |
|
|||||
|
2024
Q1 | $34.5M | Sell |
|
|||||
|
2023
Q4 | $33.5M | Sell |
|
|||||
|
2023
Q3 | $33.3M | Sell |
|
|||||
|
2023
Q2 | $41.8M | Sell |
|
|||||
|
2023
Q1 | $50.5M | Sell |
|
|||||
|
2022
Q4 | $56.2M | Sell |
|
|||||
|
2022
Q3 | $60.6M | Buy |
|
|||||
|
2022
Q2 | $63.2M | Buy |
|
|||||
|
2022
Q1 | $58M | Buy |
|
|||||
|
2021
Q4 | $51.7M | Buy |
|
|||||
|
2021
Q3 | $25.3M | Sell |
|
|||||
|
2021
Q2 | $29.3M | Buy |
|
|||||
|
2021
Q1 | $29.3M | Buy |
|
|||||
|
2020
Q4 | $21.5M | Buy |
|